Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Overall survival; Surgery; Thyroidectomy; Neck dissection; Radiotherapy; Hospital volume;
مقالات ISI کارسینوم تیروئید مدولری (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم تیروئید مدولری; Atypical carcinoid; Medullary thyroid carcinoma; Small cell carcinoma;
Keywords: کارسینوم تیروئید مدولری; Calcitonin amyloid (ACal); medullary thyroid carcinoma; systemic amyloidosis; kidney amyloidosis; amyloid-associated glomerulopathy; nephrotic syndrome; proteinuria; decreased kidney function; renal biopsy; case report;
Keywords: کارسینوم تیروئید مدولری; Clusterin; Medullary thyroid carcinoma; Thyroid tumors; Neuroendocrine tumors; Immunohistochemistry; Endocrine tumors;
Keywords: کارسینوم تیروئید مدولری; bronchogenic carcinoma; carcinoid syndrome; carcinoid tumor; flushing; gastroenteropancreatic neuroendocrine tumor; mastocytosis; medullary thyroid carcinoma; pheochromocytoma; renal cell carcinoma; vasointestinal polypeptide-secreting tumor;
Keywords: کارسینوم تیروئید مدولری; VEGF; Vascular Endothelial Growth Factor; MMP; Matrixmetalloproteinases; uPAR; UrokinasePlasminogen Activator Receptor; Ang-1; Angiotensin-1; TGF-β; Transforming Growth Factor-β; VEGFR; Vascular Endothelial Growth Factor Receptor; TKI; Tyrosine Kinase I
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Multiple endocrine neoplasia; Prophylactic surgery;
Keywords: کارسینوم تیروئید مدولری; Papillary thyroid carcinoma; Medullary thyroid carcinoma; Primary tumor diameter; Extrathyroidal extension; Lymph node metastases; Extranodal growth; Distant metastasis
Keywords: کارسینوم تیروئید مدولری; Olfactory neuroblastoma; SNUC; Basaloid squamous carcinoma; Rhabdomyosarcoma; Medullary thyroid carcinoma; Merkel cell carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Thyroid; Size; Fine needle aspiration
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; MEN type 2; Pathophysiology; Diagnosis; Treatment;
Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; RET; Epigenetics; MicroRNA; Noncoding RNA;
Resección hepática radioguiada con 18F-DOPA en un paciente con carcinoma medular de tiroides metastásico
Keywords: کارسینوم تیروئید مدولری; Carcinoma medular de tiroides; 18F-DOPA; CirugÃa radioguiada; MetastasectomÃa; Medullary thyroid carcinoma; 18F-DOPA; Radioguided surgery; Metastasectomy;
Radioguided hepatic resection with l-DOPA in metastatic medullary thyroid carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; l-Dopa Medullary; Radioguided surgery; Metastasectomy; Carcinoma medular de tiroides; l-Dopa; CirugÃa radioguiada; MetastasectomÃa;
eIF4E Phosphorylation in Prostate Cancer
Keywords: کارسینوم تیروئید مدولری; eIF4E; eukaryotic translation initiation factor 4E; mTOR; mammalian target of rapamycin; PCa; prostate cancer; Mnk; mitogen activated protein kinase interacting protein kinase; ADT; androgen deprivation therapy; MAPK; mitogen-activated protein kinase; CRP
αCGRP, another amyloidogenic member of the CGRP family
Keywords: کارسینوم تیروئید مدولری; CGRP; Calcitonin Gene Related Peptide; CT; calcitonin; IAPP; islet amyloid polypeptide; GPCR; G-Protein Coupled Receptor; RAMP; Receptor Activity Modifying Protein; T2D; Type 2 Diabetes; MTC; Medullary Thyroid Carcinoma; MD; Molecular Dynamics; CD; Circul
Original contributionHeat shock proteins HSP90, HSP70 and GRP78 expression in medullary thyroid carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Heat shock protein 70; Heat shock protein 90; GRP 78; Immunohistochemistry;
A germline RET proto-oncogene mutation in multiple members of an Arab family with variable onset of MEN type 2A-associated clinical manifestations
Keywords: کارسینوم تیروئید مدولری; ATA; The American Thyroid Association; FMTC; familial medullary thyroid carcinoma; MTC; medullary thyroid carcinoma; MEN2A; multiple endocrine neoplasia type 2; Arab; Medullary thyroid carcinoma; MEN2A; Pheochromocytoma; RET proto-oncogene;
MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma
Keywords: کارسینوم تیروئید مدولری; MiR-21; MALAT1; Medullary thyroid carcinoma; siRNA; Proliferation; Invasion;
Original contributionA study of FoxA1 expression in thyroid tumors
Keywords: کارسینوم تیروئید مدولری; FoxA1; Calcitonin; CEA; Medullary thyroid carcinoma; Follicular neoplasm; Anaplastic thyroid carcinoma;
Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents
Keywords: کارسینوم تیروئید مدولری; AUC; area under curve; BID; twice daily; GLP-1r; glucagon-like-protein-1 receptor; MTC; medullary thyroid carcinoma; PKPD; pharmacokinetics/pharmacodynamics; QW; once weekly; GLP-1r agonists; C-cell carcinogenicity; Pharmacology; PKPD modelling; Predictio
Micronutrient status (calcium, zinc, vitamins D and E) in patients with medullary thyroid carcinoma: A cross-sectional study
Keywords: کارسینوم تیروئید مدولری; Micronutrient deficiency; Medullary thyroid carcinoma; Calcium; Zinc; Vitamin D; Vitamin E;
Carcinoma medular de tiroides metastásico en mama en una paciente con diagnóstico clÃnico de neoplasia endocrina múltiple subtipo 2B: reporte de un caso
Keywords: کارسینوم تیروئید مدولری; Neoplasia endocrina múltiple subtipo 2B; Carcinoma medular de tiroides; Metástasis; Cáncer de mama; Multiple endocrine neoplasia subtype 2B; Medullary thyroid carcinoma; Metastasis; Breast cancer;
Radiothérapie postopératoire des carcinomes médullaires de la thyroïde à haut risque de rechute locorégionale
Keywords: کارسینوم تیروئید مدولری; Radiothérapie externe; Adjuvante; Postopératoire; Modulation d’intensité; Cancer médullaire de la thyroïde; Contrôle localExternal beam radiotherapy; Adjuvant; Postoperative; IMRT; Medullary thyroid carcinoma; Local control
The current role of 18F-FDOPA PET for neuroendocrine tumor imaging
Keywords: کارسینوم تیروئید مدولری; 18F-FDOPA; PET; Neuroendocrine; Gastroenteropancreatic tumors; Medullary thyroid carcinoma; Paraganglioma; Congenital hyperinsulinism18F-FDOPA; TEP; Tumeurs neuroendocrines; Tumeurs gastro-entéro-pancréatiques; Cancer médullaire de la thyroïde; Paragangli
Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy
Keywords: کارسینوم تیروئید مدولری; MNK; MAP kinase-interacting kinase; TMZ; temozolomide; GBM; glioblastoma; MTC; medullary thyroid carcinoma; ERK; extracellular signal-regulated kinases; eIF4E/G1; eukaryotic translation initiation factor 4E/G1; MAPK; mitogen-activated protein kinase; GAPD
C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; C-cell hyperplasia; Microcarcinoma; RET mutation; Prophylactic thyroidectomy; MEN2
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)
Keywords: کارسینوم تیروئید مدولری; Cabozantinib; Calcitonin; Carcinoembryonic antigen; Expert consensus; Guidelines; Medullary thyroid carcinoma; Thyroid cancer; VandetanibCabozantinib; Calcitonina; Antígeno carcinoembrionario; Consenso de expertos; Guía; Carcinoma medular de tiroides; Cán
Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes
Keywords: کارسینوم تیروئید مدولری; NF1; neurofibromatosis type 1; MEN2; Multiple Endocrine Neoplasia type 2; MTC; medullary thyroid carcinoma; CCH; C-cell hyperplasia; C-cells; parafollicular cells; CT; calcitonin; PKA; protein kinase A; Neurofibromatosis type 1; NF1 gene; RET gene; Thyroi
Clinical value of [18F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Metastasis; PET/CT; Calcitonin
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia
Keywords: کارسینوم تیروئید مدولری; calcitonin; pentagastrin; medullary thyroid carcinoma; C-cell hyperplasia; chronic kidney disease; receiver-operating characteristic analysis
MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET
Keywords: کارسینوم تیروئید مدولری; MTC; medullary thyroid carcinoma; miRNA; microRNA; RET; REarranged during Transfection proto-oncogene; TKI; tyrosine kinase inhibitor; UTR; untranslated region; GAPDH; glyceraldehyde phosphate dehydrogenase; ANOVA; analysis of variance; REarranged during
Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin
Keywords: کارسینوم تیروئید مدولری; Human calcitonin; Amyloid fibril; Osteoporosis; Medullary thyroid carcinoma;
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase
Keywords: کارسینوم تیروئید مدولری; CML; chronic myeloid leukemia; ALL; acute lymphoblastic leukemia; RET; REarranged during Transfection; GDNF; glial-derived neurotrophic factor; TKI; tyrosine kinase inhibitor; MTC; medullary thyroid carcinoma; FMTC; familial MTC; PTC; papillary thyroid ca
Medullary thyroid carcinoma in ethnic Chinese with MEN2A: A case report and literature review
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; MEN2A; Chinese; Prophylactic thyroidectomy
Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Chemotherapy; Kinase inhibitors; RET
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; microRNA; miR-375; miR-10a; miR-455; YAP1
Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China
Keywords: کارسینوم تیروئید مدولری; Prophylactic thyroidectomy; Medullary thyroid carcinoma; RET; Mutation screening; Serum calcitonin; Fully-automated chemiluminescence immunoassay
Pitfalls in the Staging of Cancer of Thyroid
Keywords: کارسینوم تیروئید مدولری; Thyroid gland; Papillary thyroid carcinoma; Medullary thyroid carcinoma; Follicular thyroid carcinoma; Anaplastic thyroid carcinoma; Extrathyroidal extension;
Valor pronóstico de las caracterÃsticas clÃnicas, histopatológicas e inmunohistoquÃmicas en el carcinoma medular de tiroides
Keywords: کارسینوم تیروئید مدولری; Carcinoma medular de tiroides; HistopatologÃa; InmunohistoquÃmica; Carcinoma familiar; Carcinoma esporádico; supervivencia; Medullary thyroid carcinoma; Histopathology; Immunohistochemical; Familial carcinoma; Sporadic carcinoma; Survival;
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary Thyroid Carcinoma; RET; RET mutation; Aneuploidy; FISH
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; positron emission tomography; PET/CT; 18F-DOPA; dihydroxyphenylalanine;
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results
Keywords: کارسینوم تیروئید مدولری; cDNA arrays; Differential diagnosis; Immunohistochemistry; Medullary thyroid carcinoma; Thyroid paraganglioma; Tissue microarray
Consensus-based management of differentiated thyroid cancer in a tertiary care set-up
Keywords: کارسینوم تیروئید مدولری; Differntiated thyroid cancer; Thyroid cancer; Papillary thyroid cancer; Thyroid oncology; Follicular thyroid carcinoma; Anaplastic thyroid carcinmoa; Medullary thyroid carcinoma
Fenotipo de la mutación C634Y del protooncogén RET en el MEN2A: a propósito de una familia
Keywords: کارسینوم تیروئید مدولری; Carcinoma medular de tiroides; Neoplasia endocrina múltiple 2; Medullary thyroid carcinoma; Multiple endocrine neoplasia type 2;
Histological and immunohistochemical profile of sporadic and familial medullary thyroid carcinoma
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Histology; Immunohistochemical; Familial carcinoma; Sporadic carcinomaCarcinoma medular de tiroides; Histología; Inmuno-histoquímica; Carcinoma familiar; Carcinoma esporádico
N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18Ink4c by the transforming mutant RETC634R
Keywords: کارسینوم تیروئید مدولری; Cell cycle; p18Ink4c; N-Myc; RET; Transcription; Initiator element; MEN2; multiple endocrine neoplasia type-2; CDK; cyclin dependent kinase; CDKI; CDK inhibitor; PTC; papillary thyroid carcinoma; MTC; medullary thyroid carcinoma; PC; pheochromocytoma; TF;
Coexistent Familial Nonmultiple Endocrine Neoplasia Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma Associated With RET Polymorphism
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Papillary thyroid carcinoma; Rearranged during transfection (RET); Polymorphism;
Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; Multiple endocrine neoplasia; RET mutation; Genotype–phenotype correlation
Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes
Keywords: کارسینوم تیروئید مدولری; Medullary thyroid carcinoma; RET proto-oncogene mutation; Prophylactic thyroidectomy; Minimally invasive video-assisted thyroidectomy